These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 395570)
21. Carcinogenesis in the Syrian hamster. SHUBIK P Acta Unio Int Contra Cancrum; 1959; 15():554-8. PubMed ID: 14446271 [No Abstract] [Full Text] [Related]
22. Carcinogen-induced melanotic tumors in the Syrian hamster. RAPPAPORT H; NAKAI T; SHUBIK P Ann N Y Acad Sci; 1963 Feb; 100():279-96. PubMed ID: 13973120 [No Abstract] [Full Text] [Related]
23. An evaluation of assay procedures for detection of tumor promotors. Sivak A Acta Pharmacol Toxicol (Copenh); 1984; 55 Suppl 2():69-88. PubMed ID: 6385623 [No Abstract] [Full Text] [Related]
24. Carcinogenic effects in the Syrian golden hamster of N-methyl-N-formylhydrazine of the false morel mushroom Gyromitra esculenta. Toth B; Patil K J Cancer Res Clin Oncol; 1979 Feb; 93(2):109-21. PubMed ID: 220266 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of species, strain, and dose effects in arylamine carcinogenesis. Weisburger JH; Fiala ES Natl Cancer Inst Monogr; 1981 Dec; (58):41-8. PubMed ID: 7200572 [No Abstract] [Full Text] [Related]
26. The significance of the hamster model in carcinogenesis testing. Grandjean CJ; Althoff J Prog Exp Tumor Res; 1979; 24():207-14. PubMed ID: 538245 [No Abstract] [Full Text] [Related]
27. Model studies in tobacco carcinogenesis with the Syrian golden hamster. Hoffmann D; Rivenson A; Hecht SS; Hilfrich J; Kobayashi N; Wynder EL Prog Exp Tumor Res; 1979; 24():370-90. PubMed ID: 395571 [No Abstract] [Full Text] [Related]
28. Ultrastructural analysis of pancreatic carcinogenesis: morphological characterization of N-nitroso-bis(2-hydroxypropyl)amine-induced neoplasms in the Syrian hamster. Flaks B; Moore MA; Flaks A Carcinogenesis; 1980 May; 1(5):423-38. PubMed ID: 7273278 [TBL] [Abstract][Full Text] [Related]
29. Carcinogenesis bioassay of prazepam (Verstran) in rats and mice. de la Iglesia FA; Barsoum N; Gough A; Mitchell L; Martin RA; Di Fonzo C; McGuire EJ Toxicol Appl Pharmacol; 1981 Jan; 57(1):39-54. PubMed ID: 7209986 [No Abstract] [Full Text] [Related]
30. Incorporation of transplacental exposure into routine carcinogenicity bioassays. Swenberg JA Natl Cancer Inst Monogr; 1979 May; (51):265-8. PubMed ID: 481580 [TBL] [Abstract][Full Text] [Related]
31. Carcinogenesis in the explanted cheek pouch of the Syrian hamster (Cricetus auratus). GHADIALLY FN; ILLMAN O J Pathol Bacteriol; 1961 Jan; 81():45-8. PubMed ID: 13704878 [No Abstract] [Full Text] [Related]
36. Chemical carcinogenesis in the Syrian golden hamster. A review. Homburger F Cancer; 1969 Feb; 23(2):313-38. PubMed ID: 4885230 [No Abstract] [Full Text] [Related]
37. ESTROGEN-INDUCED KIDNEY TUMORS IN THE GOLDEN HAMSTER. II. DIETHYLSTILBESTROL ABSORPTION AND DISTRIBUTION IN TISSUES. WARD DN; PUTCH JD; MCGREGOR RF; CHANG JP Cancer Res; 1964 Feb; 24():319-27. PubMed ID: 14115700 [No Abstract] [Full Text] [Related]
38. In vivo studies in Syrian golden hamsters: a transplacental bioassay of ten nitrosamines. Althoff J; Grandjean C Natl Cancer Inst Monogr; 1979 May; (51):251-5. PubMed ID: 481578 [TBL] [Abstract][Full Text] [Related]
39. Carcinogenesis by nitrosomorpholines, nitrosooxazolidines and nitrosoazetidine given by gavage to Syrian golden hamsters. Lijinsky W; Kovatch RM; Knutsen GL Carcinogenesis; 1984 Jul; 5(7):875-8. PubMed ID: 6733849 [TBL] [Abstract][Full Text] [Related]
40. The incidence of neoplasms in Syrian hamsters with particular emphasis on intestinal neoplasia. Fabry A Arch Toxicol Suppl; 1985; 8():124-7. PubMed ID: 3868341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]